Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,057B 11.08B 9.69B 8.94B 8.27B 15.69B 15.96B 107B 41.95B 519B 41.59B 40.69B 1,799B P/E 2027 *
24.5x
P/E 2028 * 19.9x
Enterprise Value 1,025B 10.74B 9.39B 8.66B 8.01B 15.21B 15.46B 104B 40.66B 503B 40.3B 39.43B 1,743B EV / Sales 2027 *
2.86x
EV / Sales 2028 * 2.53x
Free-Float
70.07%
Yield 2027 *
0.61%
Yield 2028 * 0.66%
1 day-1.91%
1 week-9.39%
Current month-8.21%
1 month-2.06%
3 months+1.10%
6 months+2.46%
Current year-2.01%
1 week 1,222
Extreme 1222
1,382.7
1 month 1,222
Extreme 1222
1,414.4
Current year 1,149
Extreme 1149
1,414.4
1 year 1,149
Extreme 1149
1,414.4
3 years 1,015.54
Extreme 1015.54
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Date Insider Type Main position Quantity % Market Cap.
04-01Other

Global Head of Quality and PV

35,600 0.0043%
12-18Other

GLOBAL HEAD - IPDO

70 0.0000%
12-18Other

Executive/Senior Manager

8,450 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.91%-9.39%-1.09%+20.78% 11.08B
+0.09%+0.25%+54.65%+169.19% 1,085B
-1.63%-1.50%+65.79%+62.70% 624B
-1.12%-4.27%+31.10%+84.44% 442B
+0.83%-0.44%+28.94%+27.84% 332B
-1.58%-9.02%+23.77%+29.19% 277B
+0.58%-2.14%+26.18%+45.93% 282B
+0.52%-1.30%-29.17%-39.23% 217B
-1.19%-2.81%+22.63%+66.30% 196B
-0.72%+2.72%+19.07%+81.19% 167B
Average -0.28%-2.25%+24.19%+54.83% 363.3B
Weighted average by Cap. +0.16%-1.07%+38.24%+84.95%

Financials

2027 *2028 *
Net sales 358B 3.75B 3.28B 3.03B 2.8B 5.32B 5.41B 36.26B 14.22B 176B 14.09B 13.79B 609B 396B 4.14B 3.63B 3.34B 3.09B 5.87B 5.97B 40.04B 15.69B 194B 15.56B 15.22B 673B
Net income 43.46B 455M 398M 367M 340M 645M 656M 4.4B 1.72B 21.34B 1.71B 1.67B 73.92B 53.81B 564M 493M 455M 421M 799M 812M 5.45B 2.13B 26.42B 2.12B 2.07B 91.52B
Net Debt -32.64B -342M -299M -276M -255M -485M -493M -3.3B -1.3B -16.03B -1.28B -1.26B -55.53B -54.72B -573M -502M -462M -428M -812M -826M -5.54B -2.17B -26.87B -2.15B -2.11B -93.08B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
10/07/26 1,245.50 -1.91% 399,100
09/07/26 ₹1,269.80 -5.85% 330,028
08/07/26 ₹1,348.70 -0.37% 128,018
07/07/26 ₹1,353.75 -1.10% 54,499
06/07/26 ₹1,368.75 -0.42% 45,159
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,269.80INR
Average target price
1,344.85INR
Spread / Average Target
+5.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRREDDY Stock